TrialJCO precision oncology2024

Palbociclib in Solid Tumor Patients With Genomic Alterations in the cyclinD-cdk4/6-INK4a-Rb Pathway: Results From National Cancer Institute-Children's Oncology Group Pediatric Molecular Analysis for Therapy Choice Trial Arm I (APEC1621I).

Margaret E Macy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.